Immediately recognizing, neutralizing and destroying it before we ever even have a chance to become sick. Now, when the coronavirus tries to infect us, our immune system is ready. Other cells stimulated by the protein pieces, called cytotoxic T cells, can kill virus-infected cells.

Some of these cells, called helper T cells, train B cells how to make antibodies that will fit perfectly onto the surface protein of the virus. The dendritic cell travels to a nearby lymph node, where it presents the surface proteins to other cells of the immune system. These pieces are then displayed on the surface of the dendritic cell. When ribosomes read the vaccine mRNA, pieces of the viral surface protein are made. Once inside these cells, the mRNA does not enter the cell's nucleus or interact with DNA, but remains in the cytoplasm with other mRNA molecules, waiting to create the enzymes our body needs. The mRNA in the vaccine is wrapped in a layer of fat particles that protect it and help it get taken up by specialized cells of the immune system called dendritic cells.

MRNA is a genetic material that instructs our cells to produce proteins. Antibodies that fit onto this protein can block the virus from attaching. Coronavirus mRNA vaccines teach our immune system to make these antibodies. Like many viruses, it uses a protein on its surface to attach to and enter our cells. Numerous experts have confirmed that there are few similarities between the COVID-19 spike protein and syncytin-1 and that these were not significant enough to for the immune system to be confused between the two ( here and here and here and here and here).Coronavirus. Presented here is a liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodology for the quantification of viral protein VP1, the main component of the NVLPs in this study. “Given that there are only 20 different types of amino acid, it isn’t surprising that many, many proteins share similarities”, wrote Catherine Thornton, a Professor of Human Immunology at Swansea University ( here) and April Rees, a PhD Researcher in Immunology at Swansea University in an article on the topic for The Conversation publication here. The candidate vaccine in this work comprises plant-derived Norovirus-like particles (NVLPs) which are structures that mimic the virus but lack any infectious genetic material. Syncytin-1 is made up of 538 amino acids here). Pfizer spokesperson Dervila Keane confirmed to Reuters by email previous reports ( here) that the protein targeted by their vaccine only shared a sequence of four amino acids with syncytin-1, which is too short to cause autoimmunity problems. Syncytin-1 is not contained in the SARS-CoV-2 spike protein and the SARS-CoV-2 spike protein and syncytin-1 are not very similar. The claims that these mRNA vaccines will cause the immune system to attack syncytin-1 are unfounded. The aim is for the immune system to recognise and eliminate this protein so that, if it encounters an intact SARS-CoV-2, it is prepared to target the same structure on the virus. The Pfizer/BioNTech and Moderna COVID-19 vaccines work by inserting mRNA which tells human cells to produce a sequence of amino acids that forms a protein like the “spike protein” found on the SARS-CoV-2 virus which causes COVID-19.

The brain manifestations of no Syncitin-1 are MS, Parkinsons, Schizophrenia, Psychopathy and I posit any neurodegenerative condition.” Therefore, Syncitin-1 will continue to be scavenged in the body. “The PROBLEM is, there is no mechanism to turn off or STOP the destruction of Syncitin-1 which is also found in the BRAIN and female reproductive system. One such post ( here) reads: “The mRNA vacks targets a protein called Syncitin-1 which is a protein contained in the CV spike protein complex.

Protein in vaccine